Gene Variants Associated With Deep Vein Thrombosis
Top Cited Papers
Open Access
- 19 March 2008
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA
- Vol. 299 (11) , 1306-1314
- https://doi.org/10.1001/jama.299.11.1306
Abstract
The incidence of deep vein thrombosis (DVT) is 1 per 1000 person-years.1 The 10-year recurrence risk is 30%.2 Deep vein thrombosis can lead to life-threatening pulmonary embolism.3 Deep vein thrombosis is caused by acquired and genetic risk factors. Acquired risk factors include age, hospitalization, cancer, pregnancy, hormone therapy, and surgery.2 Family and twin studies indicate that genetics accounts for about 60% of the risk for DVT.4,5 Deficiencies of natural anticoagulants antithrombin, protein C, and protein S are strong risk factors for DVT; however, the variants causing these deficiencies are rare and explain only about 1% of all DVTs.6 Two more common genetic variants, Factor V Leiden (FVL) and prothrombin G20210A, have been consistently found to be associated with DVT7,8 but still only explain a fraction of the DVT events.6 It has been suggested that 2 or more risk factors are needed for thrombosis.6,9,10Keywords
This publication has 24 references indexed in Scilit:
- Minor Injuries as a Risk Factor for Venous ThrombosisArchives of internal medicine (1960), 2008
- Incidence and mortality of venous thrombosis: a population‐based studyJournal of Thrombosis and Haemostasis, 2007
- Malignancies, Prothrombotic Mutations, and the Risk of Venous ThrombosisJAMA, 2005
- Major Genetic Susceptibility for Venous Thromboembolism in Men: A Study of Danish TwinsEpidemiology, 2003
- Deep Venous Thrombosis in a General HospitalChest, 2002
- Venous thrombosis: a multicausal diseaseThe Lancet, 1999
- An Unknown Genetic Defect Increases Venous Thrombosis Risk, through Interaction with Protein C DeficiencyAmerican Journal of Human Genetics, 1998
- Mutation in blood coagulation factor V associated with resistance to activated protein CNature, 1994
- Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia StudyThe Lancet, 1993
- Absence of Thrombosis in Subjects with Heterozygous Protein C DeficiencyNew England Journal of Medicine, 1987